L&T-MBDA join hands for missile integration facility
L&T-MBDA join hands for missile integration facility

L&T-MBDA join hands for missile integration facility

Geyatee Deshpande Article rating: 3.8

Larsen & Toubro (L&T) and arms manufacturer company-MBDA, through their joint venture-L&T MBDA Missile Systems Limited (LTMMSL) has set up a missile integration facility.

Shilpa Medicare stock surges post USFDA approval
Shilpa Medicare stock surges post USFDA approval

Shilpa Medicare stock surges post USFDA approval

Avalokita Pandey Article rating: 5.0

The share price of Shilpa Medicare gained around six per cent today, after the company received an approval from US Food and Drug Administration (USFDA) for Pirfenidone tablets, which is used to treat idiopathic pulmonary fibrosis.

Ahluwalia Contracts win order worth Rs 1,254 crore
Ahluwalia Contracts win order worth Rs 1,254 crore

Ahluwalia Contracts win order worth Rs 1,254 crore

Amir Shaikh Article rating: 5.0

Ahluwalia Contracts informed the bourses that it has secured an order worth Rs 1,254 crore from Central Public Works Department (CPWD), Jammu (J&K)

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 4.4

The market opened in the red on February 3, 2020. The previous trading session witnessed the Sensex going down by 987.96 points to end at 39,735.53 and the Nifty was down by 300.25 points to close at 11661.85. 

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 5.0

The market opened in the red on February 3, 2020. The previous trading session witnessed the Sensex going down by 987.96 points to end at 39,735.53 and the Nifty was down by 300.25 points to close at 11661.85. 

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 5.0

The market opened in the red on February 3, 2020. The previous trading session witnessed the Sensex going down by 987.96 points to end at 39,735.53 and the Nifty was down by 300.25 points to close at 11661.85.

Zydus Cadila receives nod for type 2 Diabetes treatment drug
Zydus Cadila receives nod for type 2 Diabetes treatment drug

Zydus Cadila receives nod for type 2 Diabetes treatment drug

Geyatee Deshpande Article rating: 5.0

Zydus Cadila has received an approval from Drug Controller General of India (DGIA) for the use of Saroglitazar Magnesium in the treatment of type 2 Diabetes Mellitus as an additional therapy with Metformin.

Abolition of DDT: Dividend Yield MFs to benefit?
Abolition of DDT: Dividend Yield MFs to benefit?

Abolition of DDT: Dividend Yield MFs to benefit?

Henil Shah Article rating: 5.0

With the recent Budget announcements, Finance Minister Nirmala Sitharaman abolished the Dividend Distribution Tax (DDT). So, let’s find out whether abolishing DDT would benefit dividend yield funds or not!

RSS
First22642265226622672269227122722273Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR